Lenox Wealth Management’s Biogen BIIB Stock Holding History

Lenox Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$133K	Buy	499 +104	+26%	+$31.3K	0.04%	181
2020 Q1	$124K	Buy	395 +86	+28%	+$26.1K	0.04%	173
2019 Q4	$92K	Sell	309 -48	-13%	-$13.3K	0.03%	229
2019 Q3	$83K	Buy	357 +190	+114%	+$44.2K	0.02%	226
2019 Q2	$39K	Buy	167 +95	+132%	+$21.9K	0.01%	271
2019 Q1	$17K	Buy	72 +39	+118%	+$12.3K	0.01%	377
2018 Q4	$10K	Buy	33 +15	+83%	+$4.79K	﹤0.01%	384
2018 Q3	$6K	Sell	18 -1	-5%	-$344	﹤0.01%	471
2018 Q2	$6K	Sell	19 -10	-34%	-$2.81K	﹤0.01%	410
2018 Q1	$7K	Hold	29	–	–	﹤0.01%	382
2017 Q4	$9K	Hold	29	–	–	﹤0.01%	393
2017 Q3	$9K	Hold	29	–	–	﹤0.01%	404
2017 Q2	$8K	Buy	+29	New	+$7.67K	﹤0.01%	392

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lenox Wealth Management's BIIB Position: Q2 2020 in Review

Lenox Wealth Management increased its Biogen (BIIB) stake by 26% in Q2 2020, buying an estimated $31.3K and bringing the position to 499 shares worth $133K. The position accounts for 0.04% of the portfolio, ranked #181.

Lenox Wealth Management first reported a position in BIIB in Q2 2017 and has held it in 13 quarters since. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

Lenox Wealth Management held 499 shares of Biogen worth $133K as of Q2 2020.
Lenox Wealth Management bought 104 Biogen shares in Q2 2020, an estimated $31.3K.
Biogen made up 0.04% of Lenox Wealth Management's portfolio in Q2 2020, its #181 holding.
Lenox Wealth Management first reported a position in Biogen in Q2 2017 and has held it in 13 quarters since.
1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.